Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Change in Cash (2020 - 2025)

Historic Change in Cash for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to -$13.4 million.

  • SOPHiA GENETICS's Change in Cash fell 1823.65% to -$13.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.5 million, marking a year-over-year increase of 6164.18%. This contributed to the annual value of -$39.4 million for FY2024, which is 849.51% up from last year.
  • According to the latest figures from Q3 2025, SOPHiA GENETICS's Change in Cash is -$13.4 million, which was down 1823.65% from $23.8 million recorded in Q2 2025.
  • SOPHiA GENETICS's Change in Cash's 5-year high stood at $168.8 million during Q3 2021, with a 5-year trough of -$20.5 million in Q3 2022.
  • Its 5-year average for Change in Cash is $440263.2, with a median of -$12.8 million in 2023.
  • Per our database at Business Quant, SOPHiA GENETICS's Change in Cash crashed by 124296.18% in 2023 and then soared by 161028.78% in 2025.
  • Quarter analysis of 5 years shows SOPHiA GENETICS's Change in Cash stood at -$17.2 million in 2021, then surged by 107.16% to $1.2 million in 2022, then crashed by 1242.96% to -$14.0 million in 2023, then rose by 6.64% to -$13.1 million in 2024, then decreased by 1.85% to -$13.4 million in 2025.
  • Its Change in Cash was -$13.4 million in Q3 2025, compared to $23.8 million in Q2 2025 and -$12.8 million in Q1 2025.